3 results
Approved WMOCompleted
The aim of this study is to assess the safety and efficacy of the new CaptivatorTM EMR kit.
Approved WMOCompleted
Studies to date have demonstrated a reduction in HF-related hospitalizations and improved quality of life in patients using the CardioMEMS HF System when compared with patients receiving standard of care in the United States. The purpose of this…
Approved WMORecruiting
The predictive value of the microbiome (throat swabs and stool samples) to identify patients who will relapse during durvalumab treatment after CRT (False negative Rate) at 6 months. Exploratory endpoints include the effects of antibiotic therapy…